1 September 2021
At the meeting of 4 August 2021 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
fibrosing interstitial lung disease | 85/2021 | 86/2021 |
polycythaemia vera | 87/2021 | 88/2021 |
primary myelofibrosis | 89/2021 | 90/2021 |
essential thrombocythaemia | 91/2021 | 92/2021 |
carpal tunnel syndrome | 93/2021 | 94/2021 |
myeloma | 95/2021 | 96/2021 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined Amendment Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
ischaemic heart disease | 97/2021 | 98/2021 |
Note: Ischaemic heart disease Amendment Statement of Principles No. 98 of 2021 will be published shortly.
The above SOPs take effect from 20 September 2021.
Decided to Undertake Consultation regarding:
Condition | Reasons for Decision | Date for Final Decision |
---|---|---|
aortic stenosis | Intention to remove one or more factors | December 2021 |
colorectal adenoma | Intention to remove one or more factors | December 2021 |
Finalised Declarations for:
Condition | Declaration | Reasons for Decision |
---|---|---|
malignant neoplasm of the brain | ||
malignant neoplasm of the prostate |
Completed Investigations
The above determinations and declarations conclude the previously advertised investigations into:
- fibrosing interstitial lung disease
- polycythaemia vera
- primary myelofibrosis
- essential thrombocythaemia
- carpal tunnel syndrome
- myeloma
- ischaemic heart disease (focussed review - psoriasis and psoriatic arthritis)
- malignant neoplasm of the brain (focussed review - exposure to carbamate insecticides and fungicides)
- malignant neoplasm of the prostate (focussed review - asbestos exposure)
New Investigations
Decided to advertise the following investigations:
- chronic myeloid leukaemia
- vaccine-induced thrombotic thrombocytopaenia
- pilonidal sinus (focussed review - prolonged sitting)
The above declaration and investigation notices appear in the Government Notices Gazette of 31 August 2021.